论文部分内容阅读
C677T polymorphism in the methylenetetrahydrofolate reductase(MTHFR) gene is a risk factor for stroke,suggesting that widespread detection could help to prevent stroke.DNA from 70 stroke patients and 70 healthy controls was extracted from saliva using a magnetic nanoparticles-based method and from blood using conventional methods.Real-time PCR results revealed that the C677T polymorphism was genotyped by PCR using DNA extracted from both saliva and blood samples.The genotype results were confirmed by gene sequencing,and results for saliva and blood samples were consistent.The mutation TT genotype frequency was significantly higher in the stroke group than in controls.Homocysteine levels were significantly higher than controls in both TT genotype groups.Therefore,this noninvasive magnetic nanoparticles-based method using saliva samples could be used to screen for the MTHFR C677T polymorphism in target populations.
C677T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene is a risk factor for stroke, suggesting that widespread detection could help to prevent stroke. DNA from 70 stroke patients and 70 healthy controls was extracted from saliva using a magnetic nanoparticles-based method and from blood Using conventional methods. Real-time PCR results revealed that the C677T polymorphism was genotyped by PCR using DNA extracted from both saliva and blood samples. genotype results were confirmed by gene sequencing, and results for saliva and blood samples were consistent. mutation TT genotype frequency was significantly higher in the stroke group than in controls. Homocysteine levels were significantly higher than controls in both TT genotype groups. Before, this noninvasive magnetic nanoparticles-based method using saliva samples could be used to screen for the MTHFR C677T polymorphism in target populations.